Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication
ConclusionMost of the well-established risk factors were found to be significantly associated with bleeding events in our study. We additionally found that women had a lower incidence of bleeding. Potential biases are selection effects, residual confounding and unmeasured frailty.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Alcoholism | Bleeding | Cancer | Cancer & Oncology | Cardiology | Chronic Obstructive Pulmonary | Congestive Heart Failure | Coumadin | Diabetes | Drugs & Pharmacology | Endocrinology | Heart | Heart Failure | Liver | Peripheral Vascular Disease (PVD) | Renal Failure | Stroke | Study | Sweden Health | Urology & Nephrology | Warfarin | Women